Literature DB >> 1988173

Enhanced expression of glutathione S-transferases in colorectal carcinoma compared to non-neoplastic mucosa.

M Moorghen1, J Cairns, L M Forrester, J D Hayes, A Hall, A R Cattan, C R Wolf, A L Harris.   

Abstract

Ten paired samples of primary human colorectal carcinoma and adjacent non-neoplastic mucosa were analysed for total glutathione S-transferase (GST) activities as determined by 1-chloro-2,4-dinitrobenzene assays. These tissues were also investigated for the expression of acidic (pi), basic (alpha) and neutral (mu) GSTs using Western blotting procedures and immunohistochemical staining. For each of the paired samples examined the total GST activity was higher in tumour than in adjacent non-neoplastic mucosa. Western blotting, using an antibody against acidic GST also showed strong immunoreactivity in all the samples with more intense reactions in tumour compared to mucosa in nine out of the ten paired samples. Low levels of basic GST were also expressed in all samples of tumour and mucosa. Neutral GST was not detectable in two samples of tumour and corresponding mucosa, but low levels of expression were demonstrated in the remaining eight. Immunohistochemical staining for acidic GST showed a dark brown reaction in all tumour cells; in non-neoplastic mucosa there was positive immunoreactivity for epithelial cells situated deep within the crypts and a negative reaction for surface epithelial cells. Immunohistochemical staining for basic GST was negative except for one sample of tumour and two of mucosa. Neutral GST was expressed only in two samples of tumour and two samples of mucosa. We therefore conclude that there is enhanced expression of GSTs, acidic GST being the predominant form, in tumour compared to normal mucosa, in keeping with a role for GSTs in colonic carcinogenesis and acquired or innate drug resistance.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1988173     DOI: 10.1093/carcin/12.1.13

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  11 in total

1.  Effect of Boschniakia rossica on expression of GST-P, p53 and p21(ras)proteins in early stage of chemical hepatocarcinogenesis and its anti-inflammatory activities in rats.

Authors:  Zong-Zhu Yin; Hai-Ling Jin; Xue-Zhe Yin; Tian-Zhu Li; Ji-Shu Quan; Zeng-Nan Jin
Journal:  World J Gastroenterol       Date:  2000-12       Impact factor: 5.742

2.  The expression of placental-type glutathione S-transferase (GST-pi) in human cutaneous squamous cell carcinoma and normal human skin.

Authors:  K Shimizu; F Toriyama; H Yoshida
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

3.  Influence of clinical factors, diet, and drugs on the human upper gastrointestinal glutathione system.

Authors:  H Hoensch; I Morgenstern; G Petereit; M Siepmann; W H M Peters; H M J Roelofs; W Kirch
Journal:  Gut       Date:  2002-02       Impact factor: 23.059

4.  Xenobiotic metabolising enzyme expression in colonic neoplasia.

Authors:  J A McKay; G I Murray; R J Weaver; S W Ewen; W T Melvin; M D Burke
Journal:  Gut       Date:  1993-09       Impact factor: 23.059

5.  Glutathione S-transferase in bone marrow metastases of disseminated neuroblastoma.

Authors:  A G Hall; A G McGuckin; A D Pearson; A R Cattan; A J Malcolm; M M Reid
Journal:  J Clin Pathol       Date:  1994-05       Impact factor: 3.411

Review 6.  Glutathione-related enzymes, glutathione and multidrug resistance.

Authors:  J A Moscow; K H Dixon
Journal:  Cytotechnology       Date:  1993       Impact factor: 2.058

7.  Immunoblot analysis of the placental form of glutathione S-transferase in protein extracted from paraffin-embedded human glioma tissue.

Authors:  A Hara; N Sakai; H Yamada; N Yoshimi; T Tanaka; H Mori
Journal:  J Cancer Res Clin Oncol       Date:  1993       Impact factor: 4.553

8.  Personalizing colon cancer therapeutics: targeting old and new mechanisms of action.

Authors:  Christina Leah B Kline; Wafik S El-Deiry
Journal:  Pharmaceuticals (Basel)       Date:  2013-08-21

Review 9.  Glutathione S-conjugates as prodrugs to target drug-resistant tumors.

Authors:  Emma E Ramsay; Pierre J Dilda
Journal:  Front Pharmacol       Date:  2014-08-11       Impact factor: 5.810

10.  P-glycoprotein is not expressed in a majority of colorectal carcinomas and is not regulated by mutant p53 in vivo.

Authors:  P De Angelis; T Stokke; L Smedshammer; R A Lothe; G Lehne; Y Chen; O P Clausen
Journal:  Br J Cancer       Date:  1995-08       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.